HUP0202787A2 - 5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0202787A2 HUP0202787A2 HU0202787A HUP0202787A HUP0202787A2 HU P0202787 A2 HUP0202787 A2 HU P0202787A2 HU 0202787 A HU0202787 A HU 0202787A HU P0202787 A HUP0202787 A HU P0202787A HU P0202787 A2 HUP0202787 A2 HU P0202787A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- hydrogen
- general formula
- heteroaryl
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- -1 hydroxy- Chemical class 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001624 naphthyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- BGCPLWWYPZAURQ-UHFFFAOYSA-N 5-[[5-chloro-2-(2,2,6,6-tetramethylmorpholin-4-yl)pyrimidin-4-yl]amino]-3-(3-hydroxy-3-methylbutyl)-1-methylbenzimidazol-2-one Chemical group ClC=1C(=NC(=NC=1)N1CC(OC(C1)(C)C)(C)C)NC1=CC2=C(N(C(N2CCC(C)(C)O)=O)C)C=C1 BGCPLWWYPZAURQ-UHFFFAOYSA-N 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány (I) általános képletű vegyületekre - amelyek képletében Ra(i) általános képletű csoport, amelyben P1 fenil-, naftil- vagyheteroarilcsoport; R1 halogénatom, alkil-, cikloalkil-, alkoxi-,hidroxi-, hidroxi-alkil-, nitro-, trifluor-metil-, ciano-, -SR6, -SOR6, -SO2R6, -SO2NR6R7, -CO2R6, -CONR6R7, -OCONR6R7, -NR6R7, -NR6CO2R7, -NR6CONR7R8, -CR6=NOR7 csoport; ahol R6, R7 és R8hidrogénatom vagy alkilcsoport; és a 0, 1, 2 vagy 3; vagy Ra (ii)általános képletű csoport, amelyben P2 fenil-, naftil-, heteroaril-,heterociklusos csoport; P3 fenil-, naftil- vagy heteroarilcsoport; Akémiai kötés, oxigénatom, karbonil-, metilén- vagy NR4 csoport; aholR4 hidrogénatom vagy alkilcsoport; R2 az (i) általános képletnél R1-nél meghatározott, vagy R2 adott esetben szubsztituált heteroaril-vagy heterociklusos csoport; R3 halogénatom, alkil-, cikloalkil-,alkoxi-, alkil-karbonil-, hidroxi-, nitro-, trifluor-metil-, ciano-, -CO2R6, -CONR6R7, -NR6R7 csoport, ahol R6 és R7 a fentiekbenmeghatározott; b és c 0, 1, 2 vagy 3; Y kémiai kötés, metiléncsoport,oxigénatom, NR5 csoport; R5 hidrogénatom vagy alkilcsoport; W -(CR9R10)t- csoport, ahol t 2, 3 vagy 4, valamint R9 és R10hidrogénatom vagy alkilcsoport, vagy W viniléncsoport (-CH=CH-); Rbhidrogén-, halogénatom, hidroxi-, alkil-, trifluor-metil-, alkil-karbonil-, ciano- vagy alkoxicsoport; Rc hidrogénatom vagyalkilcsoport; valamint Rd és Re alkilcsoport és gyógyászatilag elfogadható sóikra vonatkozik. A találmánykiterjed a vegyületek előállítási eljárására, gyógyászatialkalmazására, valamint a vegyületeket tartalmazógyógyszerkészítményekre is. Ó
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9922831.4A GB9922831D0 (en) | 1999-09-25 | 1999-09-25 | Novel compounds |
| GB0001936A GB0001936D0 (en) | 2000-01-27 | 2000-01-27 | Novel compounds |
| GB0013873A GB0013873D0 (en) | 2000-06-07 | 2000-06-07 | Novel compounds |
| PCT/EP2000/009442 WO2001023374A1 (en) | 1999-09-25 | 2000-09-21 | Piperazine derivatives as 5-ht1b antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202787A2 true HUP0202787A2 (hu) | 2002-12-28 |
| HUP0202787A3 HUP0202787A3 (en) | 2003-12-29 |
Family
ID=27255501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202787A HUP0202787A3 (en) | 1999-09-25 | 2000-09-21 | Piperazine derivatives as 5-ht1b antagonists, process for their preparation and pharmaceutical compositions containing them |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US6747030B1 (hu) |
| EP (1) | EP1216239B1 (hu) |
| JP (1) | JP2003510317A (hu) |
| KR (1) | KR20020030126A (hu) |
| CN (1) | CN1190432C (hu) |
| AR (1) | AR029454A1 (hu) |
| AT (1) | ATE259363T1 (hu) |
| AU (1) | AU765020B2 (hu) |
| BR (1) | BR0014279A (hu) |
| CA (1) | CA2385737A1 (hu) |
| CO (1) | CO5200839A1 (hu) |
| CZ (1) | CZ20021038A3 (hu) |
| DE (1) | DE60008262T2 (hu) |
| DK (1) | DK1216239T3 (hu) |
| ES (1) | ES2211624T3 (hu) |
| HK (1) | HK1046909B (hu) |
| HU (1) | HUP0202787A3 (hu) |
| IL (1) | IL148818A0 (hu) |
| MX (1) | MXPA02003175A (hu) |
| MY (1) | MY122391A (hu) |
| NO (1) | NO20021459L (hu) |
| NZ (1) | NZ517865A (hu) |
| PE (1) | PE20010641A1 (hu) |
| PL (1) | PL362900A1 (hu) |
| PT (1) | PT1216239E (hu) |
| TR (1) | TR200200795T2 (hu) |
| WO (1) | WO2001023374A1 (hu) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL148818A0 (en) * | 1999-09-25 | 2002-09-12 | Smithkline Beecham Plc | Piperazine derivatives as 5-ht1b |
| US6906192B2 (en) | 2000-11-07 | 2005-06-14 | Bristol Myers Squibb Company | Processes for the preparation of acid derivatives useful as serine protease inhibitors |
| AU2002227269A1 (en) | 2000-11-07 | 2002-06-03 | Bristol-Myers Squibb Company | Acid derivatives useful as serine protease inhibitors |
| GB0106419D0 (en) | 2001-03-15 | 2001-05-02 | Smithkline Beecham Plc | Novel compounds |
| GB0106586D0 (en) * | 2001-03-16 | 2001-05-09 | Smithkline Beecham Plc | Novel compounds |
| GB0224557D0 (en) * | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| JP2006527757A (ja) | 2003-06-18 | 2006-12-07 | ファイザー・プロダクツ・インク | 新規なピペラジニル−アリールオキシ−ｎ−アリールラクタムおよびピペラジニル−ヘテロアリールオキシ−ｎ−アリールラクタム |
| MX2007001106A (es) | 2004-07-28 | 2007-03-15 | Glaxo Group Ltd | Derivados de piperazina utiles para el tratamiento de trastornos gastrointestinales. |
| EP2006289B1 (en) | 2006-03-31 | 2011-11-30 | Wako Pure Chemical Industries, Ltd. | Pyrazole-type cyanine dye |
| WO2007113202A1 (en) | 2006-03-31 | 2007-10-11 | Glaxo Group Limited | Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
| HUE048859T2 (hu) | 2010-08-10 | 2020-08-28 | Rempex Pharmaceuticals Inc | Gyûrûs bórsavészter származékok, eljárás elõállításukra, és terápiás alkalmazásuk |
| WO2013033461A1 (en) | 2011-08-31 | 2013-03-07 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| CN102766139B (zh) * | 2012-08-14 | 2014-09-17 | 江苏先声药物研究有限公司 | 阿齐沙坦的多晶型物及其制备方法 |
| US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| BR112015016002A2 (pt) | 2013-01-04 | 2017-07-11 | Rempex Pharmaceuticals Inc | compostos, composições farmacêuticas, complexos químicos e respectivos usos e método para tratar ou prevenir infecção bacteriana |
| CA2894891A1 (en) | 2013-01-04 | 2014-07-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2015171398A1 (en) | 2014-05-05 | 2015-11-12 | Rempex Pharmaceuticals, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| ES2750805T3 (es) | 2014-05-05 | 2020-03-27 | Rempex Pharmaceuticals Inc | Síntesis de sales de boronato y usos de las mismas |
| EA201691988A1 (ru) | 2014-05-19 | 2017-06-30 | Ремпекс Фармасьютикалз, Инк. | Производные бороновой кислоты и их терапевтическое применение |
| US10206937B2 (en) | 2014-07-01 | 2019-02-19 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2016081297A1 (en) | 2014-11-18 | 2016-05-26 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| WO2016149393A1 (en) | 2015-03-17 | 2016-09-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| GB2543498A (en) * | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
| AU2017290060B2 (en) | 2016-06-30 | 2021-07-22 | Qpex Biopharma, Inc | Boronic acid derivatives and therapeutic uses thereof |
| BR112020007138B1 (pt) | 2017-10-11 | 2023-03-21 | Qpex Biopharma, Inc | Derivados de ácido borônico, métodos de síntese, composição farmacêutica e uso dos mesmos |
| EP3781576B1 (en) | 2018-04-20 | 2024-06-12 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE204262T1 (de) | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
| DE69417427T2 (de) * | 1993-09-03 | 1999-11-25 | Smithkline Beecham P.L.C., Brentford | Indol- und indolin-derivate als 5ht1d rezeptor antagonisten |
| WO1998027058A2 (en) | 1996-12-19 | 1998-06-25 | Smithkline Beecham Plc | N-piperazin-1-ylphenyl-benzamide derivatives |
| JP2001524116A (ja) | 1997-04-18 | 2001-11-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ１ａ、５ｈｔ１ｂおよび５ｈｔ１ｄ受容体アンタゴニスト活性を合わせ持つインドール誘導体 |
| EP0975614A1 (en) * | 1997-04-18 | 2000-02-02 | Smithkline Beecham Plc | A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
| GB9725931D0 (en) | 1997-12-05 | 1998-02-04 | Smithkline Beecham Plc | Novel compounds |
| IL148818A0 (en) * | 1999-09-25 | 2002-09-12 | Smithkline Beecham Plc | Piperazine derivatives as 5-ht1b |
-
2000
- 2000-09-21 IL IL14881800A patent/IL148818A0/xx unknown
- 2000-09-21 BR BR0014279-4A patent/BR0014279A/pt not_active IP Right Cessation
- 2000-09-21 EP EP00967803A patent/EP1216239B1/en not_active Expired - Lifetime
- 2000-09-21 CN CNB008162697A patent/CN1190432C/zh not_active Expired - Fee Related
- 2000-09-21 DK DK00967803T patent/DK1216239T3/da active
- 2000-09-21 TR TR2002/00795T patent/TR200200795T2/xx unknown
- 2000-09-21 NZ NZ517865A patent/NZ517865A/en unknown
- 2000-09-21 KR KR1020027003825A patent/KR20020030126A/ko not_active Ceased
- 2000-09-21 DE DE60008262T patent/DE60008262T2/de not_active Expired - Fee Related
- 2000-09-21 JP JP2001526526A patent/JP2003510317A/ja active Pending
- 2000-09-21 HK HK02108463.9A patent/HK1046909B/en not_active IP Right Cessation
- 2000-09-21 CZ CZ20021038A patent/CZ20021038A3/cs unknown
- 2000-09-21 CA CA002385737A patent/CA2385737A1/en not_active Abandoned
- 2000-09-21 MX MXPA02003175A patent/MXPA02003175A/es active IP Right Grant
- 2000-09-21 AU AU77836/00A patent/AU765020B2/en not_active Ceased
- 2000-09-21 US US10/089,013 patent/US6747030B1/en not_active Expired - Fee Related
- 2000-09-21 PL PL00362900A patent/PL362900A1/xx not_active Application Discontinuation
- 2000-09-21 HU HU0202787A patent/HUP0202787A3/hu unknown
- 2000-09-21 PT PT00967803T patent/PT1216239E/pt unknown
- 2000-09-21 AT AT00967803T patent/ATE259363T1/de not_active IP Right Cessation
- 2000-09-21 WO PCT/EP2000/009442 patent/WO2001023374A1/en not_active Ceased
- 2000-09-21 ES ES00967803T patent/ES2211624T3/es not_active Expired - Lifetime
- 2000-09-22 MY MYPI20004437A patent/MY122391A/en unknown
- 2000-09-22 PE PE2000000989A patent/PE20010641A1/es not_active Application Discontinuation
- 2000-09-22 CO CO00072095A patent/CO5200839A1/es not_active Application Discontinuation
- 2000-09-22 AR ARP000104983A patent/AR029454A1/es not_active Application Discontinuation
-
2002
- 2002-03-22 NO NO20021459A patent/NO20021459L/no not_active Application Discontinuation
-
2004
- 2004-03-17 US US10/802,236 patent/US20040176388A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20021459D0 (no) | 2002-03-22 |
| DE60008262D1 (de) | 2004-03-18 |
| HK1046909B (en) | 2004-12-03 |
| HK1046909A1 (en) | 2003-01-30 |
| CN1399635A (zh) | 2003-02-26 |
| NO20021459L (no) | 2002-03-22 |
| AU765020B2 (en) | 2003-09-04 |
| MY122391A (en) | 2006-04-29 |
| US6747030B1 (en) | 2004-06-08 |
| IL148818A0 (en) | 2002-09-12 |
| CZ20021038A3 (cs) | 2002-08-14 |
| ES2211624T3 (es) | 2004-07-16 |
| AR029454A1 (es) | 2003-07-02 |
| HUP0202787A3 (en) | 2003-12-29 |
| ATE259363T1 (de) | 2004-02-15 |
| CO5200839A1 (es) | 2002-09-27 |
| PE20010641A1 (es) | 2001-07-14 |
| WO2001023374A1 (en) | 2001-04-05 |
| EP1216239B1 (en) | 2004-02-11 |
| EP1216239A1 (en) | 2002-06-26 |
| MXPA02003175A (es) | 2002-09-30 |
| DE60008262T2 (de) | 2004-12-16 |
| DK1216239T3 (da) | 2004-06-14 |
| CN1190432C (zh) | 2005-02-23 |
| JP2003510317A (ja) | 2003-03-18 |
| US20040176388A1 (en) | 2004-09-09 |
| KR20020030126A (ko) | 2002-04-22 |
| AU7783600A (en) | 2001-04-30 |
| PT1216239E (pt) | 2004-05-31 |
| CA2385737A1 (en) | 2001-04-05 |
| NZ517865A (en) | 2003-11-28 |
| BR0014279A (pt) | 2002-05-21 |
| PL362900A1 (en) | 2004-11-02 |
| TR200200795T2 (tr) | 2002-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0202787A2 (hu) | 5-HT1B antagonista piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| DE60010076D1 (de) | Chinolinderivate als antibakterielle mittel | |
| WO2007137030A3 (en) | Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives | |
| DK1678166T3 (da) | Proteinkinaseinhibitorer | |
| HUP0203971A2 (hu) | Imidazoimidazolok és -triazolok mint gyulladásellenes szerek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| NO20060664L (no) | N-substituerte benzimidazolyl C-kit inhibitorer | |
| BRPI0509364B8 (pt) | derivados de tetraidroquinolina, composição farmacêutica que os compreende e um processo por preparar os referidos derivados | |
| HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
| DE60001623D1 (de) | Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel | |
| WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
| NO20061432L (no) | N3 alkylerte benzimidazolederivater som MEK-inhibitorer | |
| ATE323687T1 (de) | Benzolsulfonamid-derivate und ihre anwendung als arzneimittel | |
| AR039127A1 (es) | Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| HUP0303070A2 (hu) | 3,4-Dihidro-izokinolin-származékok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények | |
| MY129796A (en) | Novel anti-inflammatory androstane derivatives | |
| DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
| BR0108816A (pt) | Derivados de quinolina como antagonistas alfa-2 | |
| TR200302047T4 (tr) | Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri. | |
| MY139887A (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same. | |
| MX2009007954A (es) | Derivado de heterocicliden-n-(aril) acetamida. | |
| ATE211740T1 (de) | Substituierte indazolderivate | |
| AP1564A (en) | Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use. | |
| AR005233A1 (es) | Derivados de 1,2,3,4-tetrahidroquinolina, procesos para su preparacion, una composicion farmaceutica y el uso en la elaboracion de un medicamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |